Author:
Hartman Jenny,Härmark Linda,van Puijenbroek Eugène
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference21 articles.
1. World Health Organisation (2002) The importance of pharmacovigilance—safety monitoring of medicinal products. WHO.
http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf
. Accessed 22 October 2016
2. CIOMS Working group VIII (2010) Practical aspects of signal detection in pharmacovigilanc: report of CIOMS working group VIII. CIOMS, Geneva
3. Pacurariu AC, Coloma PM, van Haren A, Genov G, Sturkenboom MC, Straus SM (2014) A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee. Drug Saf 37(12):1059–1066
4. Lester J, Neyarapally GA, Lipowski E, Graham CF, Hall M, Dal PG (2013) Evaluation of FDA safety-related drug label changes in 2010. Pharmacoepidemiol Drug Saf 22(3):302–305
5. Inman WH (1996) Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol 41(5):434–435
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献